mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |